Penn Medicine
Help | Search | Site Map | Contact   
faculty photo

Karam C. Mounzer, MD

Clinical Professor of Medicine (Infectious Diseases)
Attending Physician, Penn Presbyterian Medical Center
Department: Medicine

Contact information
Philadelphia Fight
1233 Locust Street
Philadelphia, PA 19107
Office: 215-790-1788
Fax: 215-732-5490
Bachelor (Experimental Sciences and French Literature)
College Notre Dame de Jamhour, Beirut, Lebanon, 1985.
MD (Pre-Med & Med combined)
Saint Joseph University, Faculty of Medicine, Beirut, Lebanon , 1992.
Post-Graduate Training
Internal Medicine, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, 1992-1993.
Residency, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School , 1993-1995.
Infectious Diseases Fellowship, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School , 1995-1997.
Diplomate, American Board of Internal Medicine , 1995.
Diplomate, American Board of Infectious Diseases , 1997.
ABIM Internal Medicine, 2015.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Description of Research Expertise

Clinical Development of new antiretroviral agents

Description of Clinical Expertise

Treatment of Multi drug Resistant HIV virus, HIV-HCV co-infection

Description of Other Expertise

Suboxone Clinic for HIV infected opioid-addicted patients

Selected Publications

McMyn NF, Varriale J, Fray EJ, Zitzmann C, MacLeod H, Lai J, Singhal A, Moskovljevic M, Garcia MA, Lopez BM, Hariharan V, Rhodehouse K, Lynn K, Tebas P, Mounzer K, Montaner LJ, Benko E, Kovacs C, Hoh R, Simonetti FR, Laird GM, Deeks SG, Ribeiro RM, Perelson AS, Siliciano RF, Siliciano JM: The latent reservoir of inducible, infectious HIV-1 does not decrease despite decades of antiretroviral therapy. J Clin Invest Sept 2023.

Neergaard R, Jones NL, Roebuck C, Rendle KA, Barbati Z, Peterson B, Tebas P, Mounzer K, Metzger D, Montaner LJ, Dube K, Barg FK.: "I Know That I Was a Part of Making a Difference": Participant Motivations for Joining a Cure-Directed HIV Trial with an Analytical Treatment Interruption. AIDS Res Hum Retroviruses August 2023.

Mounzer K, Brunet L, Fusco JS, McNicholl IR, Dunbar M, Sension M, McCurdy LH, Fusco GP: Immune response to ART initiation in advanced HIV infection. HIV Med 24(6):716-726, June 2023.

Tebas P, Lynn K, Azzoni L, Cocchella G, Papasavvas E, Fair M, Karanam B, Sharma P, Reeves JD, Petropoulos CJ, Lalley-Chareczko L, Kostman JR, Short W, Mounzer K, Montaner : Susceptibility to 3BNC117 and 10-1074 in ART suppressed chronically infected persons. LJ.AIDS Apr 2023.

Tietjen I, Schonhofer C, Sciorillo A, Naidu ME, Haq Z, Kannan T, Kossenkov AV, Rivera-Ortiz J, Mounzer K, Hart C, Gyampoh K, Yuan Z, Beattie KD, Rali T, Shuda McGuire K, Davis RA, Montaner LJ: The Natural Stilbenoid (-)-Hopeaphenol Inhibits HIV Transcription by Targeting Both PKC and NF-κB Signaling and Cyclin-Dependent Kinase 9. Antimicrob Agents Chemother April 2023.

Raad M, Abou Haidar M, Ibrahim R, Rahal R, Abou Jaoude J, Harmouche C, Habr B, Ayoub E, Saliba G, Sleilaty G, Mounzer K, Saliba R, Riachy M: Stenotrophomonas maltophilia pneumonia in critical COVID-19 patients. Sci Rep Feb 2023.

Paul E.Sax, Joseph J.Eron, Janna Radtchenko, Megan Dunbar, Joshua Gruber, Moshe Fridman, Moti Ramgopal, Karam Mounzer, Gregory Huhn, Steven Santiago, Richard A.Elion: WHAT INFLUENCES SWITCHING TO DTG/3TC VS B/F/TAF IN CLINICAL PRACTICE? CROI 2023.

M.Betina Pampena, Pablo Tebas, Livio Azzoni, Emmanouil Papasavvas, Matthew Fair, Karam Mounzer, Luis J.Montaner, Michael R.Betts: EVALUATION OF HIV-SPECIFIC T CELL RESPONSE IN BEAT2 CLINICAL TRIAL. CROI 2023.

Eion Plenn, Frances K Barg, Katharine Rendle, Andrea Bilger, Christopher Roebuck, Beth Peterson, Pablo Tebas, Karam Mounzer, David Metzger, Luis J.Montaner, Karine Dube: PARTICIPANT EXPERIENCES IN A CURE-DIRECTED LONG-TERM ANALYTIC TREATMENT INTERRUPTION. CROI 2023.

Richard A. Elion1, Andrew Frick1, Janna Radtchenko1, Supriya Sarkar2, Gayathri Sridhar2, Joseph J. Eron3, Karam Mounzer4, Jean Van Wyk5, Vani Vannappagari2 : Real-World Utilization and Effectiveness of Long-Acting Cabotegravir and Rilpivirine Among People with HIV with Detectable Viral Loads at Initiation: Trio Cohort Study ID WEEK 2023.

back to top
Last updated: 09/17/2023
The Trustees of the University of Pennsylvania
© The Trustees of the University of Pennsylvania. Site best viewed with a supported browser.
SOM Home International Programs Penn Alumni Clinical Trials Centers and Institutes Departments Faculty Research Education Administration